DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Household
Updated 1m ago
ELLX.F logo

Elixinol Wellness LimitedOTCPK:ELLX.F Stock Report

Market Cap US$2.4m
Updated 1m ago
Share Price
n/a
1Y41.4%
7D11.1%
1D11.1%
Portfolio Value
​
View

Elixinol Wellness Limited

OTCPK:ELLX.F Stock Report

Market Cap: US$2.4m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Elixinol Wellness (ELLX.F) Stock Overview

A holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. More details

ELLX.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Risk Analysis

Shareholders have been substantially diluted in the past year

Has less than 1 year of cash runway

Highly volatile share price over the past 3 months compared to the US market

Does not have a meaningful market cap ($2M)


ELLX.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW442,510 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
B
BlackGoat
R
RockeTeller
I
Investingwilly
D
davidlsander
442,510 investors already sharing narratives
US$
Current Price
US$0.0141.2% undervalued intrinsic discount
%/yr
Decrease
Increase
PastFuture-161m35m2016201920222025202620282031Revenue AU$31.8mEarnings AU$3.2m
Advanced
View all narratives

Elixinol Wellness Limited Competitors

Paranovus Entertainment Technology

Symbol: NasdaqCM:PAVS
Market cap: US$2.4m

Synergy CHC

Symbol: NasdaqCM:SNYR
Market cap: US$1.5m

Cyanotech

Symbol: OTCPK:CYAN
Market cap: US$3.5m

DSwiss

Symbol: OTCPK:DQWS
Market cap: US$6.6m

Price History & Performance

Summary of share price highs, lows and changes for Elixinol Wellness
Historical stock prices
Current Share PriceAU$0.01
52 Week HighAU$0.022
52 Week LowAU$0.0024
Beta2.21
1 Month Change150.00%
3 Month Change20.48%
1 Year Change41.44%
3 Year Change-69.51%
5 Year Change-98.26%
Change since IPO-99.90%

Recent News & Updates

Recent updates

Shareholder Returns

ELLX.FUS Personal ProductsUS Market
7D11.1%-5.8%-0.9%
1Y41.4%-7.7%13.9%

Return vs Industry: ELLX.F exceeded the US Personal Products industry which returned -7.7% over the past year.

Return vs Market: ELLX.F exceeded the US Market which returned 13.9% over the past year.

Price Volatility

Is ELLX.F's price volatile compared to industry and market?
ELLX.F volatility
ELLX.F Average Weekly Movement131.9%
Personal Products Industry Average Movement9.3%
Market Average Movement6.9%
10% most volatile stocks in US Market15.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: ELLX.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ELLX.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2017n/aNatalie Butlerwww.elixinolwellness.com

Elixinol Wellness Limited, a holding company, produces and sells human nutrition, human wellness, pet wellness, and superfood ingredients in Australia, the Americas, and internationally. The company offers its products under Hemp Foods Australia, Mt Elephant, The Healthy Chef, Soul Foods, Ananda Equine, and Field Day brands. It distributes its products through grocery, wholesale, and e-commerce channels for white label customers, as well as food, beverage, and beauty manufacturers.

Elixinol Wellness Limited Fundamentals Summary

How do Elixinol Wellness's earnings and revenue compare to its market cap?
ELLX.F fundamental statistics
Market capUS$2.37m
Earnings (TTM)-US$2.53m
Revenue (TTM)US$11.37m
0.2x
P/S Ratio
-0.9x
P/E Ratio

Is ELLX.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ELLX.F income statement (TTM)
RevenueAU$15.90m
Cost of RevenueAU$9.13m
Gross ProfitAU$6.76m
Other ExpensesAU$10.29m
Earnings-AU$3.53m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)-0.0085
Gross Margin42.54%
Net Profit Margin-22.22%
Debt/Equity Ratio59.0%

How did ELLX.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/14 09:44
End of Day Share Price 2026/09/09 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Elixinol Wellness Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John HesterBell Potter
Siddharth RajeevFundamental Research Corp.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide